AAAAAA

   
Results: 1-11 |
Results: 11

Authors: BUGGINS AGS HIRST WJR DARLING D GAKEN J PAGLIUCA A FARZANEH F MUFTI GJ
Citation: Ags. Buggins et al., SUBVERSION OF CELL-MEDIATED-IMMUNITY BY LEUKEMIC-CELLS - LESSONS FOR CLINICAL IMMUNOTHERAPY, British Journal of Haematology, 101, 1998, pp. 2-2

Authors: HIRST WJR BUGGINS AGS PAGLIUCA A MUFTI GJ
Citation: Wjr. Hirst et al., CENTRAL ROLE OF SOLUBLE IMMUNOSUPPRESSIVE FACTORS IN THE DEVELOPMENT OF LEUKEMIA-ASSOCIATED IMMUNE DYSFUNCTION, British Journal of Haematology, 101, 1998, pp. 38-38

Authors: THOMPSON LJ LALLOZ MRA HIRST WJR LAYTON DM
Citation: Lj. Thompson et al., MOLECULAR-BASIS FOR VARIABLE CLINICAL EXPRESSION OF WISKOTT-ALDRICH SYNDROME, British Journal of Haematology, 101, 1998, pp. 169-169

Authors: BUGGINS AGS HIRST WJR PAGLIUCA A MUFTI GJ
Citation: Ags. Buggins et al., VARIABLE EXPRESSION OF CD3-ZETA AND ASSOCIATED PROTEIN-TYROSINE KINASES IN LYMPHOCYTES FROM PATIENTS WITH MYELOID MALIGNANCIES, British Journal of Haematology, 100(4), 1998, pp. 784-792

Authors: GAKEN JA HOLLINGSWORTH SJ HIRST WJR BUGGINS AGS GALEALAURI J PEAKMAN M KUIPER M PATEL P TOWNER P PATEL PM COLLINS MKL MUFTI GJ FARZANEH F DARLING DC
Citation: Ja. Gaken et al., IRRADIATED NC ADENOCARCINOMA CELLS TRANSDUCED WITH BOTH B7.1 AND INTERLEUKIN-2 INDUCE CD4(-MEDIATED REJECTION OF ESTABLISHED TUMORS()), Human gene therapy, 8(4), 1997, pp. 477-488

Authors: HIRST WJR BUGGINS A DARLING D GAKEN J FARZANEH F MUFTI GJ
Citation: Wjr. Hirst et al., ENHANCED IMMUNE COSTIMULATORY ACTIVITY OF PRIMARY ACUTE MYELOID-LEUKEMIA BLASTS AFTER RETROVIRUS-MEDIATED GENE-TRANSFER OF B7.1, Gene therapy, 4(7), 1997, pp. 691-699

Authors: HIRST WJR BUGGINS AGS DARLING D GAKEN J TOWNER P FARZANEH F MUFTI GJ
Citation: Wjr. Hirst et al., LOSS OF CD3-ZETA EXPRESSION IS A LATE EVENT IN THE DEVELOPMENT OF T-CELL DYSFUNCTION IN A MURINE LEUKEMIC MODEL, Blood, 88(10), 1996, pp. 3420-3420

Authors: BUGGINS AGS HIRST WJR PAGLIUCA A MUFTI GJ
Citation: Ags. Buggins et al., CD3-ZETA EXPRESSION IN NK AND T-CELLS FROM PATIENTS WITH MYELOID MALIGNANCIES, Blood, 88(10), 1996, pp. 2326-2326

Authors: HIRST WJR MUFTI GJ
Citation: Wjr. Hirst et Gj. Mufti, THE RATE OF DISEASE PROGRESSION PREDICTS THE QUALITY OF REMISSIONS FOLLOWING INTENSIVE CHEMOTHERAPY FOR MYELODYSPLASTIC SYNDROMES, Leukemia research, 18(11), 1994, pp. 797-804

Authors: HIRST WJR LAYTON DM SINGH S MIELIVERGANI G CHESSELLS JM STROBEL S PRITCHARD J
Citation: Wjr. Hirst et al., HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS - EXPERIENCE AT 2 UK CENTERS, British Journal of Haematology, 88(4), 1994, pp. 731-739

Authors: HIRST WJR MUFTI GJ
Citation: Wjr. Hirst et Gj. Mufti, MANAGEMENT OF MYELODYSPLASTIC SYNDROMES, British Journal of Haematology, 84(2), 1993, pp. 191-196
Risultati: 1-11 |